CAS: 13708-12-8; 5-Methylquinoxaline

相似化合物

6344-72-5 141234-08-4 64931-22-2

上下游产品

glyoxal sodium bisulfite 3-methyl-1,2-benzenediamine 5-(2,6-dimethylphenyl)-1-phenyl-1H-1,2,5-triazapentadiene Glyoxal 5-methylquinoxaline 1-oxide 5-methylquinoxaline N,N'-dioxide 5-Dibromomethyl-quinoxaline 5-(bromomethyl)-quinoxaline

Ar-甲基-Ar-硝基苯胺置于氢气,碳酸氢钠体系中,用 乙醇,水 用作溶剂,化学反应 2.25H,反应生成5-甲基喹喔啉
参考文献:8-甲基喹喔啉在混合酸中的硝化
标题:8-甲基喹喔啉在混合酸中的硝化
摘要:8-甲基喹喔啉在 40-50 oc 下通过简单的混合酸硝化方案在 C-5 处被有效地硝化.讨论了 C-6 卤素官能化和混合酸条件的修改对相对转化率和工艺安全性的影响.6-卤代-8-甲基喹喔啉的竞争副反应包括在 C-6 的水解和在 C-7 或 C-5 的卤化.
Doi:10.1021/op0340255

专利信息

专利号:CN-113828342-A
优先权日:2021-09-30
标 题:Cu-Pd-CeO2/γ-Al2O3Preparation of @ NP catalyst and synthesis of benzopyrazine compounds

专利号:US-10308615-B2
优先权日:2015-05-29
标 题:Heterocyclic compounds as inhibitors of Vanin-1 enzyme
发明人：CASIMIRO-GARCIA AGUSTIN; CONDON JEFFREY SCOTT; FLICK ANDREW CHRISTOPHER; GOPALSAMY ARIAMALA; KIRINCICH STEVEN J; MATHIAS JOHN PAUL; STROBACH JOSEPH WALTER; XIANG JASON SHAOYUN; XING LI HUANG; WANG XIAOLUN
权利人:PFIZER
摘要:Compounds, pharmaceutically acceptable salts thereof, are disclosed wherein the compounds have the structure of n nas defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

专利号:CN-107460497-A
优先权日:2017-07-07
标 题 :Electrochemical catalytic synthesis of acyl-substituted electron-deficient nitrogen-containing heterocyclic compounds

专利号:CN-113828342-B
优先权日:2021-09-30
标题 :Preparation of Cu-Pd-CeO2/γ-Al2O3@NP catalyst and synthesis of benzopyrazine compounds

专利号:CN-113774411-A
优先权日:2021-09-22
标题 :A kind of method for electrochemical synthesis of aryl-substituted quinoxaline (ketone) derivatives

专利号:CN-114524773-B
优先权日:2022-03-03
标 题:Synthesis method of aryl quinoxaline compound promoted by mechanical force